AXT INC (AXTI)

US00246W1036 - Common Stock

3.81  +0.06 (+1.6%)

After market: 3.78 -0.03 (-0.79%)

Fundamental Rating

2

Overall AXTI gets a fundamental rating of 2 out of 10. We evaluated AXTI against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AXTI is valued expensive at the moment.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AXTI has reported negative net income.
AXTI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: AXTI reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.81%, AXTI is doing worse than 64.49% of the companies in the same industry.
AXTI's Return On Equity of -8.35% is on the low side compared to the rest of the industry. AXTI is outperformed by 65.42% of its industry peers.
Industry RankSector Rank
ROA -4.81%
ROE -8.35%
ROIC N/A
ROA(3y)1.17%
ROA(5y)0.66%
ROE(3y)1.67%
ROE(5y)1.02%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AXTI has a Gross Margin of 18.10%. This is amonst the worse of the industry: AXTI underperforms 81.31% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
AXTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-13.43%

More info and screens

2

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXTI has more shares outstanding
Compared to 5 years ago, AXTI has more shares outstanding
The debt/assets ratio for AXTI is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.88, we must say that AXTI is in the distress zone and has some risk of bankruptcy.
AXTI's Altman-Z score of 0.88 is on the low side compared to the rest of the industry. AXTI is outperformed by 71.03% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that AXTI is not too dependend on debt financing.
The Debt to Equity ratio of AXTI (0.27) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACCN/A
WACC11.95%

2.3 Liquidity

A Current Ratio of 2.27 indicates that AXTI has no problem at all paying its short term obligations.
AXTI has a worse Current ratio (2.27) than 67.29% of its industry peers.
AXTI has a Quick Ratio of 1.08. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.08, AXTI is doing worse than 80.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.08

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AXTI have decreased strongly by -290.48% in the last year.
Looking at the last year, AXTI shows a very negative growth in Revenue. The Revenue has decreased by -34.57% in the last year.
AXTI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.84% yearly.
EPS 1Y (TTM)-290.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y-7.38%
Revenue growth 5Y-5.84%
Sales Q2Q%16.92%

3.2 Future

AXTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.16% yearly.
Based on estimates for the next years, AXTI will show a very strong growth in Revenue. The Revenue will grow by 32.67% on average per year.
EPS Next Y68.21%
EPS Next 2Y53.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.85%
Revenue Next 2Y32.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AXTI is valuated quite expensively with a Price/Forward Earnings ratio of 25.63.
AXTI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXTI is cheaper than 62.62% of the companies in the same industry.
AXTI is valuated rather expensively when we compare the Price/Forward Earnings ratio to 20.07, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.63

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AXTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AXTI's earnings are expected to grow with 53.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.16%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXT INC

NASDAQ:AXTI (5/31/2024, 7:24:49 PM)

After market: 3.78 -0.03 (-0.79%)

3.81

+0.06 (+1.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap168.59M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -8.35%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.1%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.27
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-290.48%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y68.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y-7.38%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y